+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Preclinical Imaging Market by Product (Modalities, Reagents), Application (Drug Discovery, Research & Development), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968721
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Preclinical Imaging Market size was estimated at USD 2.53 billion in 2023, USD 2.69 billion in 2024, and is expected to grow at a CAGR of 6.53% to reach USD 3.93 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Preclinical Imaging Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Preclinical Imaging Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Preclinical Imaging Market, highlighting leading vendors and their innovative profiles. These include Angstrom Advanced Inc., Aspect Imaging Ltd., Berthold Technologies, Bruker Corporation, FUJIFILM Holdings America Corporation, General Electric Company, INDEC BioSystems, KUBTEC Technology, LI-COR, Inc., Mediso Ltd., MILabs B.V, Miltenyi Biotec GmbH, MR Solutions Group, Peira bvba, Scitech Pty Ltd., and Siemens A.G.

Market Segmentation & Coverage

This research report categorizes the Preclinical Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Modalities
      • Magnetic Particle Imaging
      • Magnetic Resonance Imaging
      • Micro-Computed Tomography
      • Optical Imaging
      • Positron Emission Tomography
      • Single-Photon Emission Computed Tomography
    • Reagents
      • Bioluminescent Imaging Reagents
      • Fluorescent Imaging Reagents
      • MRI Contrasting Reagents
      • PET Radioactive Tracers
      • Ultrasound Contrasting Reagents
      • X-ray CT Contrasting Reagents
  • Application
    • Drug Discovery
    • Research & Development
  • End-User
    • Biotech Companies
    • Pharmaceutical Companies
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Preclinical Imaging Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Preclinical Imaging Market?
  3. What are the technology trends and regulatory frameworks in the Preclinical Imaging Market?
  4. What is the market share of the leading vendors in the Preclinical Imaging Market?
  5. Which modes and strategic moves are suitable for entering the Preclinical Imaging Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Preclinical Imaging Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adaptation of diagnostic imaging
5.1.1.2. Rising demand for non-invasive diagnostics and therapeutic devices
5.1.1.3. Growing number of clinical research organizations (CROs) and pharmaceutical companies
5.1.2. Restraints
5.1.2.1. Lack of reimbursement coverage
5.1.3. Opportunities
5.1.3.1. Technological advancements in molecular imaging
5.1.3.2. Increase in preclinical research funding, by both private and public organizations
5.1.4. Challenges
5.1.4.1. Strict regulatory framework preclinical research
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Preclinical Imaging Market, by Product
6.1. Introduction
6.2. Modalities
6.3.1. Magnetic Particle Imaging
6.3.2. Magnetic Resonance Imaging
6.3.3. Micro-Computed Tomography
6.3.4. Optical Imaging
6.3.5. Positron Emission Tomography
6.3.6. Single-Photon Emission Computed Tomography
6.3. Reagents
6.4.1. Bioluminescent Imaging Reagents
6.4.2. Fluorescent Imaging Reagents
6.4.3. MRI Contrasting Reagents
6.4.4. PET Radioactive Tracers
6.4.5. Ultrasound Contrasting Reagents
6.4.6. X-ray CT Contrasting Reagents
7. Preclinical Imaging Market, by Application
7.1. Introduction
7.2. Drug Discovery
7.3. Research & Development
8. Preclinical Imaging Market, by End-User
8.1. Introduction
8.2. Biotech Companies
8.3. Pharmaceutical Companies
8.4. Research Institutes
9. Americas Preclinical Imaging Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Preclinical Imaging Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Preclinical Imaging Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Angstrom Advanced Inc.
13.1.2. Aspect Imaging Ltd.
13.1.3. Berthold Technologies
13.1.4. Bruker Corporation
13.1.5. FUJIFILM Holdings America Corporation
13.1.6. General Electric Company
13.1.7. INDEC BioSystems
13.1.8. KUBTEC Technology
13.1.9. LI-COR, Inc.
13.1.10. Mediso Ltd.
13.1.11. MILabs B.V
13.1.12. Miltenyi Biotec GmbH
13.1.13. MR Solutions Group
13.1.14. Peira bvba
13.1.15. Scitech Pty Ltd.
13.1.16. Siemens A.G
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. PRECLINICAL IMAGING MARKET RESEARCH PROCESS
FIGURE 2. PRECLINICAL IMAGING MARKET SIZE, 2023 VS 2030
FIGURE 3. PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PRECLINICAL IMAGING MARKET DYNAMICS
FIGURE 7. PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. PRECLINICAL IMAGING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 8. PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 16. PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. PRECLINICAL IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. PRECLINICAL IMAGING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. CANADA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. CANADA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 47. CANADA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 48. CANADA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. CANADA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 52. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 53. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. CHINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. CHINA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 74. CHINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 75. CHINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. CHINA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. INDIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. INDIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 79. INDIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 80. INDIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. INDIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 89. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 90. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 119. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 120. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 133. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 135. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 136. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 140. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 141. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 145. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 146. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 150. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 151. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 155. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 156. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. ITALY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. ITALY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 165. ITALY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 166. ITALY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. ITALY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 180. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 181. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. POLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. POLAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 185. POLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 186. POLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. POLAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. QATAR PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. QATAR PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 190. QATAR PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 191. QATAR PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. QATAR PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 208. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 210. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 211. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 225. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 226. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 239. PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 240. PRECLINICAL IMAGING MARKET LICENSE & PRICING

Companies Mentioned

  • Angstrom Advanced Inc.
  • Aspect Imaging Ltd.
  • Berthold Technologies
  • Bruker Corporation
  • FUJIFILM Holdings America Corporation
  • General Electric Company
  • INDEC BioSystems
  • KUBTEC Technology
  • LI-COR, Inc.
  • Mediso Ltd.
  • MILabs B.V
  • Miltenyi Biotec GmbH
  • MR Solutions Group
  • Peira bvba
  • Scitech Pty Ltd.
  • Siemens A.G

Methodology

Loading
LOADING...

Table Information